Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by bioAffinity Technologies, Inc.
bioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFO
August 23, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales
August 14, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies Announces Closing of Registered Direct Offering, Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million
August 05, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million
August 02, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung
July 09, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests
June 12, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes
May 15, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies News Update
May 02, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
April 24, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
April 09, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
April 01, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
March 08, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
March 06, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung
March 05, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
bioAffinity Technologies News Update
February 21, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice
February 06, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
bioAffinity Technologies In The News
January 30, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors
December 05, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024
November 30, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post
November 28, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening
November 15, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update
November 14, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales
November 06, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference
October 10, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference
September 07, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update
August 14, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
AMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung Cancer
July 12, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics Symposium
June 15, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies Presents Research Findings at CYTO 2023
May 22, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
BIAFW
bioAffinity Technologies Reports First Quarter 2023 Financial Results
May 15, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
Tickers
BIAF
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.